# Artemether-Lumefantrine Clinical Effectiveness Study

> **NCT01599000** · PHASE4 · COMPLETED · sponsor: **Papua New Guinea Institute of Medical Research** · enrollment: 159 (actual)

## Conditions studied

- Parasitologically Confirmed; Malarial

## Interventions

- **DRUG:** Artemether-lumefantrine combination

## Key facts

- **NCT ID:** NCT01599000
- **Lead sponsor:** Papua New Guinea Institute of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2012-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599000, "Artemether-Lumefantrine Clinical Effectiveness Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01599000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*